Orange Book product · Brand (NDA)
ZUPLENZ
ONDANSETRON
At a glance
Jul 02, 2010
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 02, 2010
16 yr 2 mo ago
Today
Patent 8580830 expires
Listed drug product patent expiration.
Nov 23, 2029
in 3 yr 6 mo
Patent 9095577 expires
Listed drug product patent expiration.
Jul 13, 2030
in 4 yr 2 mo
Pharmaceutical detail
Active ingredient
ONDANSETRON
Strength
4MG
Dosage form
FILM
Route
ORAL
TE code
Not listed
Application
NDA 022524
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1999ZOFRAN ODTBrand (NDA)
NDA 020781 · SANDOZ
- 2023ONDANSETRONGeneric (ANDA)
ANDA 209389 · IPCA LABS LTD
- 2011ONDANSETRONGeneric (ANDA)
ANDA 078602 · SUN PHARM INDS LTD
- 2010ONDANSETRONGeneric (ANDA)
ANDA 090469 · AUROBINDO PHARMA
- 2007ONDANSETRONGeneric (ANDA)
ANDA 078050 · SANDOZ
- 2007ONDANSETRONGeneric (ANDA)
ANDA 077557 · SUN PHARM INDS
- 2007ONDANSETRONGeneric (ANDA)
ANDA 078152 · GLENMARK PHARMS LTD
- 2007ONDANSETRONGeneric (ANDA)
ANDA 076693 · BARR
- 2007ONDANSETRONGeneric (ANDA)
ANDA 077717 · NESHER PHARMS
- 2007ONDANSETRONGeneric (ANDA)
ANDA 078139 · PHARMOBEDIENT
- 2007ONDANSETRONGeneric (ANDA)
ANDA 076810 · TEVA
- 2006ONDANSETRONGeneric (ANDA)
ANDA 077406 · CHARTWELL MOLECULES
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8580830 | Nov 23, 2029 | in 3 yr 6 mo | Product |
| 9095577 | Jul 13, 2030 | in 4 yr 2 mo | Product |

